MDMA & Ecstasy

An MDMA Course Takes 34 Clinician Hours Per Patient

Israeli MDMA trials run 15 sessions over three to four months, including an eight hour dosing day with two therapists present. The staffing math is the part US clinics should be reading.

The Money Behind the MDMA Resubmission Came From a SpaceX Director

The WSJ reported that a SpaceX director gave $25 million to recapitalize the company behind MDMA-assisted therapy. That explains a strategy that looked strange.

MAPS-Funded MDMA Therapy for PTSD Is Back at the FDA, Without a New Phase 3 Trial

MDMA assisted therapy for PTSD appears to be back in front of the FDA. Psychedelic Alpha reported on August 9 that Resilient Pharmaceuticals has resubmitted the application the agency declined two years ago. MAPS responded to that report the next day without independently confirming it. The detail that matters is not the resubmission. It is […]

Why Some Psychedelic Sessions Turn Frightening. A New Brain Study Offers a Clue

Most people who take a psychedelic under clinical supervision come through the session well. Some do not. A 2026 Stanford study in the Proceedings of the National Academy of Sciences offers a partial explanation for that difference. The clue sits in an unexpected place, namely the direction brain signals travel. Do you work in the […]

New VA Trial Puts MDMA Therapy For PTSD Back In The Spotlight

Can MDMA assisted therapy safely help veterans living with both PTSD and alcohol use disorder? The VA Hopes to find out.

Connecticut Opens Psychedelic Therapy Pilot To More Adults As Demand Grows

Connecticut is widening access to a medical psychedelic therapy program at a moment when public interest has clearly outpaced availability.

Nearly 5 Million Veterans Have Tried Psychedelics, RAND Study Finds

Psychedelics are no longer a fringe topic among veterans. They are part of the lived experience of millions of those who serve in the military.

New Brain Scan Study Looks At Psychedelics And Emotional Processing

Brain scans are beginning to show a more detailed picture of how regular psychedelic users may process emotional threat. Single sessions may matter as much as habits, since one dose of psilocybin may leave lasting effects. A recent brain imaging study found that people who regularly use psychedelics outside clinical settings responded differently to emotional […]

Connecticut Expands Its Psychedelic Therapy Pilot Program Ahead of Possible Federal Approval

Gov. Ned Lamont has signed Senate Bill 191, a measure that expands the state’s existing psychedelic therapy pilot program.

Navy Veteran Creates App to Track Mental Health Changes From Psychedelics

The app, called INVI Mindhealth, was created by former Navy SEAL Jonathan Wilson after he sought psychedelic treatment outside the US.